Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Microsoft Stock Analysis 2025–2026: AI Cloud Growth, Azure Revenue Expansion, and Capital Investment Outlook

Microsoft Corporation enters the 2025–2026 fiscal period with sustained double-digit growth across revenue and earnings, supported primarily by cloud computing and artificial intelligence adoption. Quarterly revenue reached $81.3 billion, increasing 17% in constant currency. Operating income rose 21%, while earnings per share climbed 24% …

Vinay Lochav | 02 March 2026

Meta Platforms Stock Analysis 2025–2026: AI Investment Surge, Advertising Growth, and Financial Outlook

Meta Platforms entered 2026 following a year of robust financial expansion. In the fourth quarter of 2025, total revenue reached $58.9 billion, representing a 25% year-over-year increase. Advertising remained the dominant contributor, with Family of Apps ad revenue of $58.1 billion, up 24% (23% …

Vinay Lochav | 02 March 2026

Xponential Fitness (NYSE:XPOF) Crashes 47% — Structural Breakdown or Capitulation Opportunity?

Xponential Fitness (NYSE:XPOF) plunged 47.08% to $4.26 on February 27, 206, wiping out nearly half itsmarket capitalizationin one session, with volume crossing 1.02 million shares and indicating aggressive institutional selling rather than retail-drivenvolatility.

Aditi Sarkar | 02 March 2026

PAR Technology (NYSE:PAR) Drops 27% as SaaS Growth Concerns Hit Market Sentiment

PAR Technology (NYSE:PAR) dropped 27.03% to $16.39 on February 27, 2026, as investors reacted to concerns over slowing growth in the restaurant SaaS sector.

Aditi Sarkar | 02 March 2026

LiveWire Group (NYSE: LVWR) Slides 28% — EV Motorcycle Demand Under Scrutiny

LiveWire Group (NYSE:LVWR) fell 28.21% to $1.68 on February 27, 2026, signaling deep skepticism toward EV motorcycle demand and scale economics.

Aditi Sarkar | 02 March 2026

Emergent BioSolutions (NYSE: EBS) Falls 26% — Post-Pandemic Revenue Normalization

Emergent BioSolutions (NYSE:EBS) fell 26.58% to $8.15 as investors responded to ongoing post-pandemicrevenuenormalization. The decline reflects reduced demand for pandemic-related products, highlighting the company’s exposure to fluctuations in vaccine sales and government contracts.

Aditi Sarkar | 02 March 2026

Ginkgo Bioworks (NYSE:DNA) Falls 30% — Growth Narrative Reset in Synthetic Biology

Ginkgo Bioworks (NYSE:DNA) declined 30.48% to $6.75 on February 27, 2026 with heavy selling pressure reflecting a repricing of long-duration biotech growth stocks and volume exceeding 3M shares, indicating broad participation.

Aditi Sarkar | 02 March 2026

Global Risk-Off Wave Deepens as Middle East Escalation Drives Oil Spike, Dollar Strength, and Equity Selloff

Market Movers:On Friday, the top gainers were KORE Group Holdings, Inc. (+78.64%), followed by Applied Optoelectronics, Inc. (+56.88%). On the contrary, Atrium Therapeutics, Inc. (-79.74%), and Xponential Fitness, Inc. (-47.08%) declined the most the same day.

Team Kalkine | 02 March 2026

Oil’s Sharpest Move Since Pandemic Era as Geopolitical Risk Reprices Energy Markets

Key HighlightsWTI crude trades near $72.53 versus prior close of $67.28, a gain of over 7%.• Largest single-session percentage advance since 2022.• Brent-WTI spread widens as global risk premium expands.• Oil volatility index spikes, reflecting elevated liquidity stress.• Inflation expectations and rate path assumptions …

Nitish Kishor | 02 March 2026

U.S. Markets Set for Risk-Off Open as Geopolitical Escalation and Oil Surge Rattle Sentiment — March 2, 2026

United States equity markets are positioned for a lower open on Monday, March 2, 2026, as investors digest a sharp “risk-off” shift tied to weekend geopolitical developments and the resulting jump in energy prices.Early indications from index futures point to broad downside pressure, with …

Team Kalkine | 02 March 2026